Full Professor(heuristic)

Dementia and Cognitive Impairment Research · Psychiatry and Mental health

h-index62
i10-index122
Publications168
Citations16,007

Grants

8 total · 3 active

NIH #5F32GM154475-02

Gadusol: An ancient sunscreen that protects metazoan development

Expiring Soon
Amount
$76K
Period
2024-09-162026-09-15
PIs
1
Est. capacity / PI
~0 students

Awarded at UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH

NIH #1F32GM154475-01

Gadusol: An ancient sunscreen that protects metazoan development

Expiring Soon
Amount
$74K
Period
2024-09-162026-09-15
PIs
1
Est. capacity / PI
~0 students

Awarded at UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH

NIH #1U19AI171443-01

HTS Core

Active
Amount
$2.5M
Period
2022-05-162026-10-31
PIs
1
Est. capacity / PI
~3 students

Awarded at SCRIPPS RESEARCH INSTITUTE, THE

Student capacity is a rough estimate from remaining award size, split equally among PIs. Actual funding decisions vary.

All Grants

8 total · 3 active

NIH #5F32GM154475-02

Gadusol: An ancient sunscreen that protects metazoan development

Expiring Soon
Amount
$76K
Period
2024-09-162026-09-15
PIs
1
Est. capacity / PI
~0 students

Awarded at UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH

NIH #1F32GM154475-01

Gadusol: An ancient sunscreen that protects metazoan development

Expiring Soon
Amount
$74K
Period
2024-09-162026-09-15
PIs
1
Est. capacity / PI
~0 students

Awarded at UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH

NIH #1U19AI171443-01

HTS Core

Active
Amount
$2.5M
Period
2022-05-162026-10-31
PIs
1
Est. capacity / PI
~3 students

Awarded at SCRIPPS RESEARCH INSTITUTE, THE

NIH #5R01NS094721-05

An Orally Bioavailable Drug Candidate for Spinal Muscular Atrophy

Amount
$798K
Period
2016-04-012020-06-30
PIs
1
Est. capacity / PI
~0 students

Awarded at SCRIPPS RESEARCH INSTITUTE, THE

NIH #6R01NS094721-04

An Orally Bioavailable Drug Candidate for Spinal Muscular Atrophy

Amount
$329K
Period
2016-04-012020-03-31
PIs
1
Est. capacity / PI
~0 students

Awarded at SCRIPPS RESEARCH INSTITUTE, THE

NIH #5R01NS094721-03

An Orally Bioavailable Drug Candidate for Spinal Muscular Atrophy

Amount
$151K
Period
2016-04-012018-09-30
PIs
1
Est. capacity / PI
~0 students

Awarded at CALIFORNIA INSTITUTE/BIOMEDICAL RESEARCH

NIH #5K99GM088408-02

The role of IL-7 in guiding developing B cells through the pre-B cell check-point

Amount
$90K
Period
2009-07-012011-08-31
PIs
1
Est. capacity / PI
~0 students

Awarded at NEW YORK UNIVERSITY SCHOOL OF MEDICINE

NIH #1K99GM088408-01

The role of IL-7 in guiding developing B cells through the pre-B cell check-point

Amount
$90K
Period
2009-07-012011-06-30
PIs
1
Est. capacity / PI
~0 students

Awarded at NEW YORK UNIVERSITY SCHOOL OF MEDICINE